An all-purpose plasma purification system based on centrifugal plasma separation method

By combining centrifugal separation of plasma and plasma dialysis filtration adsorption technology, the problems of high blood collection flow and incomplete toxin removal of plasma replacement and dialysis methods in the prior art were solved, and efficient plasma purification for patients with liver failure was achieved and bleeding was reduced. Risk, suitable for patients with poor coagulation function.

CN108310503BActive Publication Date: 2024-11-05THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201810129418.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2018-02-08
Publication Date
2024-11-05
Estimated Expiration
2038-02-08

AI Technical Summary

Technical Problem

In the treatment of patients with acute or chronic acute liver failure, plasma replacement, plasma adsorption and hemodialysis have problems such as high blood collection flow, coagulation dysfunction, high risk of bleeding, and incomplete toxin removal, which are particularly unsuitable for coagulation function. Poor patients with advanced liver failure.

Method used

Adopt an all-round plasma purification system based on centrifugal separation method, combining plasma replacement, dialysis filtration and adsorption technology, and realize efficient plasma purification and recycling through a centrifugal plasma separator and plasma dialysis filtration adsorption device, and reduce blood collection flow , reduce the risk of coagulation function and expand the scope of treatment application.

Benefits of technology

The comprehensive removal of protein-bound toxins and water-soluble toxins has been achieved, which reduces the risk of bleeding in the treatment, improves the safety and efficiency of treatment, and is suitable for patients with middle and late stage liver failure with poor coagulation function, and expands the model of artificial liver treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN108310503B_ABST
    Figure CN108310503B_ABST
Patent Text Reader

Abstract

The present invention discloses an all-purpose plasma purification system based on centrifugal plasma separation method, including a plasma exchange device and a plasma diafiltration adsorption device, wherein the plasma exchange device includes a centrifugal plasma separator, and the plasma purification system also includes a plasma transfer device, wherein the plasma transfer device includes a plasma transfer bag and a waste pulp bag, a plasma transfer pipeline is provided between the plasma output end of the plasma exchange device and the plasma transfer bag, a plasma discharge pipeline is provided between the plasma transfer bag and the waste pulp bag, and a plasma circulation pipeline is provided between the output end of the plasma diafiltration adsorption device and the plasma discharge pipeline. The plasma purification system of the present invention can give full play to the advantages of centrifugal plasma exchange, plasma diafiltration, and plasma dual adsorption treatment, and meet the different plasma flow rate requirements of centrifugal plasma exchange, plasma diafiltration, and plasma adsorption, and has the advantages of more comprehensive functions and wider application range.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a medical instrument for blood purification, and in particular to a versatile plasma purification system (VPPS) based on a centrifugal plasma separation method. Background Art

[0002] Acute liver failure or acute-on-chronic liver failure is severe and progresses rapidly, and is prone to multiple organ failure. If the progression of the disease cannot be stopped in the short term, it will be life-threatening and require an emergency liver transplant. Patients with acute or acute-on-chronic liver failure have a large amount of toxins in their bodies, accompanied by coagulation disorders, and patients with advanced liver failure have a more serious tendency to bleed. Artificial liver is a blood purification method used to treat liver failure. At present, there are four basic artificial liver methods at home and abroad: plasma exchange, plasma adsorption, hemodialysis and hemofiltration. When performing artificial liver treatment on patients with severe liver failure, we must not only take into account the risk of bleeding, but also comprehensively remove all kinds of toxins accumulated in the body, including protein-bound toxins and water-soluble toxins. Different blood purification methods remove different liver failure toxins. Combined treatment can remove more toxins and enhance the purification effect.

[0003] Albumin dialysis adsorption is represented by the molecular adsorption recirculation system (MARS). Its working principle is to use 20% albumin solution (500-600 ml) as a medium for binding and transporting protein toxins in the albumin dialysis cycle, so that the toxins bound to proteins and other types of toxin molecules in the patient's blood are transferred to the albumin solution through the MARS dialysis membrane, and then purified by dialysis, resin and activated carbon adsorption in sequence after the protein solution purification and regeneration cycle. The purified albumin solution can be recycled again; after the adsorber adsorption reaches saturation, the albumin can no longer be used and is discarded. MARS uses albumin to transport toxins to achieve indirect adsorption of toxins by the adsorber, and is affected by the toxin exchange efficiency of the dialysis membrane. Its toxin removal efficiency is not as good as plasma adsorption. Since there is no plasma supplementation, it cannot improve the coagulation function and hypoproteinemia of patients with liver failure, and is not suitable for patients with advanced liver failure. In addition, each MARS treatment consumes and discards a large amount of albumin, which is not easy to be widely used in China. However, its scheme of resin, activated carbon adsorption and simultaneous dialysis purification is worth learning from. If plasma exchange, plasma adsorption and dialysis and / or filtration can be combined, it can not only completely remove protein-bound toxins and water-soluble toxins, replenish albumin and coagulation factors, but also make full use of waste plasma after purification and then autologous transfusion. This can greatly reduce the amount of clinical plasma used, fully meet the needs of patients with liver failure, and effectively treat more patients.

[0004] Plasma exchange requires that part of the patient's blood be drawn out of the body, and the plasma containing a large amount of toxins is separated and discarded through centrifugal or membrane separation of plasma, while fresh plasma is replenished. The membrane separation plasma method requires a relatively large blood flow rate of 100~120 ml / min, and the intraoperative heparin dosage is relatively large. For patients with mid-to-late stage liver failure with poor coagulation function, there is a risk of bleeding and hematoma; the blood flow rate of hemodialysis and hemofiltration is as high as 200~350 ml / min, and all three treatments require deep vein catheterization or arterial puncture. Deep vein catheterization or arterial puncture in patients with liver failure causes many intraoperative and postoperative complications and high risks. Once bleeding or hematoma occurs, it seriously affects subsequent treatment and the prognosis is extremely poor. The blood collection flow rate of centrifugal separation plasma exchange is only 30~60 ml / min, and deep vein catheterization is not required. Peripheral superficial vein puncture can meet the blood flow rate required for treatment. The dosage of heparin is relatively small, resulting in a small risk of bleeding. It can remove protein-bound toxins and supplement bioactive substances such as coagulation factors and albumin, which is suitable for the treatment of patients with poor coagulation function. However, simple plasma exchange cannot completely remove all kinds of toxins, especially the limited ability to remove water-soluble toxins. There is also a risk of inducing hepatic coma in patients with severe liver failure. In addition, clinical use is limited by insufficient plasma supply. Therefore, patients with severe liver failure need to be treated with plasma diafiltration and plasma adsorption in combination to maximize the removal of protein-bound toxins and water-soluble toxins. In order to improve the efficiency of plasma filtration and adsorption, the plasma separated by the centrifugal plasma exchanger needs to be accelerated from 25~30 ml / min, so that it can pass through the blood filter and two plasma adsorbers (adsorbing different types of toxins) at a high speed of 150~180 ml / min, and then be returned to the patient at a speed of 25~30 ml / min.

[0005] A Chinese patent document with document number CN203280813U discloses a plasma exchange adsorption filtration purification system equipped with a plasma storage bag. The system combines plasma exchange, plasma adsorption and plasma dialysis. First, plasma exchange is performed for 1 hour, followed by 5 hours of plasma high-speed circulation adsorption and plasma dialysis through a specially designed plasma storage bag. However, its structure is complex and can only operate on the basis of membrane plasma separation. It requires deep venous catheterization and has a high risk of treatment. It is not suitable for patients with advanced liver failure with poor coagulation function.

[0006] The Chinese patent document with the document number CN205073379U discloses a purification system and its application method that can simultaneously complete slow plasma exchange, plasma adsorption and filtration by using a specially designed plasma shunt and replacement pipeline, replacement and adsorption plasma confluence pipeline, and only one ordinary blood purification instrument with 4 pumps. However, it can only operate on the basis of membrane plasma separation and is not suitable for patients with advanced liver failure with poor coagulation function. In addition, the plasma speed during plasma adsorption and filtration is 25~30ml / min, which is insufficient to remove water-soluble toxins. Summary of the invention

[0007] The technical problem to be solved by the present invention is to overcome the shortcomings of the prior art and provide a plasma purification system that adopts centrifugal separation plasma exchange and combines plasma diafiltration and adsorption. The system can give full play to the advantages of centrifugal plasma exchange, plasma diafiltration and plasma dual adsorption treatment in one artificial liver treatment, and meet the different requirements of centrifugal plasma exchange, plasma diafiltration and plasma adsorption on plasma flow rate, and has more comprehensive functions and a wider range of applications.

[0008] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0009] A universal plasma purification system based on centrifugal plasma separation method comprises a plasma exchange device and a plasma diafiltration adsorption device, wherein the plasma exchange device comprises a centrifugal plasma separator, and the plasma purification system further comprises a plasma transfer device for collecting separated plasma or circulating purified plasma, wherein the plasma transfer device comprises a plasma transfer bag and a waste plasma bag, a plasma transfer pipeline is provided between the plasma output end of the plasma exchange device and the plasma transfer bag, a plasma discharge pipeline is provided between the plasma transfer bag and the waste plasma bag, and a plasma circulation pipeline is provided between the output end of the plasma diafiltration adsorption device and the plasma discharge pipeline.

[0010] As a further improvement of the above technical solution:

[0011] The height of the connection port between the plasma transfer bag and the plasma transfer pipeline is lower than the height of the connection port between the plasma transfer bag and the plasma discharge pipeline.

[0012] The input end of the centrifugal plasma separator is connected to a blood collection blood line for collecting patient blood, the output end of the centrifugal plasma separator is connected to a blood cell output line and a plasma output line, the plasma output line is connected to the plasma transfer line, the output end of the plasma output line is connected to the input end of the plasma diafiltration adsorption device, the plasma exchange device also includes a plasma return line for returning plasma and a blood return line for returning the treated blood to the patient, the output ends of the blood cell output line and the plasma return line are both connected to the input end of the blood return line, the input end of the plasma return line is connected to the output end of the plasma diafiltration adsorption device, and the input end of the plasma return line is connected to a fresh plasma line for replenishing fresh plasma.

[0013] The plasma diafiltration adsorption device comprises a filtrate input pipeline, a plasma diafiltration adsorption pipeline for diafiltration adsorption of plasma, and a plasma circulation return pipeline for circulating or returning purified plasma. The input end of the plasma diafiltration adsorption pipeline is connected to the output end of the plasma output pipeline, the output ends of the plasma diafiltration adsorption pipeline and the filtrate input pipeline are both connected to the input end of the plasma circulation return pipeline, and the output end of the plasma circulation return pipeline is respectively connected to the input ends of the plasma return pipeline and the plasma circulation pipeline.

[0014] The plasma dialysis filtration adsorption pipeline is sequentially provided with a blood filter, a first plasma adsorber and a second plasma adsorber, the lower side hole of the blood filter is connected to a dialysate input pipeline, and the upper side hole of the blood filter is connected to a dialysate discharge pipeline.

[0015] The plasma circulation pipeline is provided with a first connection port that can be connected or disconnected, a second connection port that can be connected or disconnected is provided between the plasma output pipeline and the plasma diafiltration adsorption pipeline, and a third connection port that can be connected or disconnected is provided between the plasma circulation return pipeline and the plasma return pipeline, and tube clamps are provided on both sides of the first connection port, the second connection port and the third connection port.

[0016] The blood collection tube line is provided with a blood collection pump, and the speed of the blood collection pump is 50-60 ml / min. The plasma output pipeline is provided with a plasma separation pump, and the speed of the plasma separation pump is 25-30 ml / min. The plasma return pipeline is provided with a plasma input pump, and the speed of the plasma input pump is 25-30 ml / min. The plasma dialysis filtration adsorption pipeline is provided with a plasma circulation drive pump, and the speed of the plasma circulation drive pump is 150-180 ml / min. The dialysate input pipeline is provided with a dialysate pump, and the speed of the dialysate pump is 50-60 ml / min. The dialysate discharge pipeline is provided with a waste liquid pump, and the speed of the waste liquid pump is 100-120 ml / min. The filtrate input pipeline is provided with a filtrate pump, and the speed of the filtrate pump is 50-60 ml / min.

[0017] A first liquid pot and a first liquid level detection sensor for detecting the liquid level of the first liquid pot are provided on the blood collection tube line, a second liquid pot and a second liquid level detection sensor for detecting the liquid level of the second liquid pot are provided on the plasma dialysis filtration adsorption tube line, a third liquid pot and a third liquid level detection sensor for detecting the liquid level of the third liquid pot are provided on the blood return tube line, a fourth liquid pot and a fourth liquid level detection sensor for detecting the liquid level of the fourth liquid pot are provided on the filtrate input tube, and a fifth liquid pot and a fifth liquid level detection sensor for detecting the liquid level of the fifth liquid pot are provided on the plasma return tube.

[0018] The first liquid pot, the second liquid pot and the third liquid pot are all provided with pressure detection connecting pipes.

[0019] The first liquid pot and the second liquid pot are both connected to a heparin pump.

[0020] The plasma return pipeline is provided with a first heating component, and the end of the plasma circulation return pipeline connected to the plasma return pipeline is provided with a second heating component.

[0021] A fresh plasma bag is provided at the input end of the fresh plasma pipeline, a dialysate bag is provided at the input end of the dialysate input pipeline, a waste liquid bag is provided at the output end of the dialysate discharge pipeline, and a filtrate bag is provided at the input end of the filtrate input pipeline. The dialysate bag, waste liquid bag and filtrate bag are all provided with hanging scales for monitoring weight.

[0022] The plasma exchange device is connected to a computer control system that independently controls the plasma exchange device, and the plasma diafiltration adsorption device is connected to a computer control system that independently controls the plasma diafiltration adsorption device.

[0023] Compared with the prior art, the advantages of the present invention are:

[0024] The all-purpose plasma purification system based on centrifugal plasma separation method of the present invention comprises a plasma exchange device, a plasma diafiltration adsorption device and a plasma transfer device. The plasma exchange device adopts a centrifugal plasma separator. The present invention successfully combines centrifugal plasma separation technology with membrane blood purification technology (diafiltration adsorption), combines the advantages of the above two technologies, overcomes the shortcomings of the above two technologies, separates plasma by centrifugation, has low requirements for blood collection flow rate, does not need to use deep vein catheterization to meet treatment needs, improves the safety of treatment, and enables artificial liver treatment to be extended to patients with middle and late stage liver failure with poor coagulation function; circulates part of the purified plasma through the plasma transfer device, solves the contradiction between the low-speed plasma separation of the centrifugal plasma separator and the high plasma flow rate required by the plasma diafiltration adsorption device, enables the separated waste plasma to be subjected to high-speed dialysis, filtration and adsorption circulation purification, and gives full play to the treatment advantages of various purification methods. The plasma transfer bag can play the role of temporarily storing waste plasma, circulating and transferring part of the purified plasma and buffering pressure. The present invention can realize the combined treatment of centrifugal plasma exchange, plasma diafiltration and plasma adsorption. When there is a lack of plasma or plasma exchange is not needed, the system can be used to perform plasma diafiltration and adsorption treatment on the separated plasma, expanding the artificial liver treatment mode of centrifugal plasma separation method, realizing the comprehensive removal of protein-bound toxins and water-soluble toxins, and expanding more comprehensive plasma purification functions on the basis of its existing safety. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 Schematic diagram of the structure of the universal plasma purification system of this embodiment.

[0026] Figure 2 It is a schematic diagram of plasma exchange performed by the universal plasma purification system of this embodiment.

[0027] Figure 3 It is a schematic diagram of the universal plasma purification system of this embodiment performing plasma diafiltration adsorption.

[0028] Legend:

[0029] 1. Plasma exchange device; 11. Centrifugal plasma separator; 12. Blood collection tube circuit; 121. Blood collection pump; 122. First liquid pot; 123. First liquid level detection sensor; 13. Blood cell output pipeline; 14. Plasma output pipeline; 141. Plasma separation pump; 142. Second connection port; 15. Plasma return pipeline; 151. Plasma input pump; 152. Fifth liquid pot; 153. Fifth liquid level detection sensor; 154. First heating component; 16. Blood return tube circuit; 161. Third liquid pot; 162. Third liquid level detection sensor; 17. Fresh plasma pipeline; 171. Fresh plasma bag; 2. Plasma diafiltration adsorption device; 21. Filtrate input pipeline; 211. Filtrate pump; 212. Fourth liquid pot; 213. Fourth liquid level detection sensor; 214. Filtrate Liquid bag; 22, plasma dialysis filtration adsorption pipeline; 221, plasma circulation drive pump; 222, second liquid pot; 223, second liquid level detection sensor; 224, dialysate input pipeline; 2241, dialysate pump; 2242, dialysate bag; 225, dialysate discharge pipeline; 2251, waste liquid pump; 2252, waste liquid bag; 226, blood filter; 227, first plasma adsorber; 228, second plasma adsorber; 23, plasma circulation return pipeline; 231, third connection port; 232, second heating component; 3, plasma transfer device; 31, plasma transfer bag; 32, waste plasma bag; 33, plasma transfer pipeline; 34, plasma discharge pipeline; 35, plasma circulation pipeline; 351, first connection port; 4, tube clamp; 5, pressure detection connecting tube; 6, heparin pump. DETAILED DESCRIPTION

[0030] The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.

[0031] like Figure 1As shown, the all-purpose plasma purification system based on the centrifugal plasma separation method of this embodiment includes a plasma exchange device 1 and a plasma diafiltration adsorption device 2, the plasma exchange device 1 includes a centrifugal plasma separator 11, the plasma purification system also includes a plasma transfer device 3 for collecting separated plasma or circulating purified plasma, the plasma transfer device 3 includes a plasma transfer bag 31 and a waste plasma bag 32, a plasma transfer pipeline 33 is provided between the plasma output end of the plasma exchange device 1 and the plasma transfer bag 31, a plasma discharge pipeline 34 is provided between the plasma transfer bag 31 and the waste plasma bag 32, a plasma circulation pipeline 35 is provided between the output end of the plasma diafiltration adsorption device 2 and the plasma discharge pipeline 34, and a pipe clamp 4 is provided at the inlet of the waste plasma bag 32. The plasma purification system includes three parts: a centrifugal plasma exchange device 1, a plasma diafiltration adsorption device 2 and a plasma transfer device 3 which serves to connect the first two devices. The centrifugal plasma exchange has a small blood collection flow rate and high treatment safety, and is suitable for patients with mid-to-late stage liver failure. Plasma diafiltration adsorption can remove protein-bound toxins and water-soluble toxins to the maximum extent, but requires a higher plasma flow rate. The plasma transfer device 3 circulates part of the purified plasma to the plasma diafiltration adsorption device 2 to meet its high plasma flow rate requirement. At the same time, multiple circulations can purify the plasma more thoroughly. Therefore, centrifugal plasma exchange and plasma diafiltration adsorption are successfully combined to give full play to their respective treatment advantages and achieve better treatment effects.

[0032] In this embodiment, the height of the connection between the plasma transfer bag 31 and the plasma transfer pipeline 33 is lower than the height of the connection between the plasma transfer bag 31 and the plasma discharge pipeline 34. In this way, when only plasma exchange is performed, the plasma with a higher toxin concentration that is separated first is continuously discharged to the waste plasma bag 32 under the push of the subsequent plasma entering the bag. After the plasma exchange is completed, the plasma with a lower toxin concentration that remains in the plasma transfer bag 31 is the last to enter the bag, which is relatively easy to purify. In addition, when the exchange and dialysis filtration adsorption combined treatment are performed, part of the plasma will be circulated. The lower connection port of the plasma transfer pipeline 33 can prevent the air in the plasma transfer bag 31 from entering the plasma dialysis filtration adsorption device 2 during circulation. At the same time, the waste plasma remaining in the plasma transfer bag 31 can first enter the plasma dialysis filtration adsorption device 2 for purification, and the plasma that re-enters the plasma transfer bag 31 after purification also enters the plasma dialysis filtration adsorption device 2 for circulation purification. In addition to transferring plasma, the plasma transfer bag 31 also acts as a pressure relief bag to prevent excessive pressure in the plasma circulation pipeline 35 because its volume can change according to the pressure change in the plasma circulation pipeline 35. Observing the liquid level height of the plasma transfer bag 31 can also be used to understand the dynamic balance of liquid flow in and out of the bag.

[0033] In this embodiment, the input end of the centrifugal plasma separator 11 is connected to a blood collection blood line 12 for collecting blood from a patient, the output end of the centrifugal plasma separator 11 is connected to a blood cell output line 13 and a plasma output line 14, the plasma output line 14 is connected to a plasma transfer line 33, the output end of the plasma output line 14 is connected to the input end of the plasma diafiltration adsorption device 2, the plasma exchange device 1 also includes a plasma return line 15 for returning plasma and a return blood line 16 for returning the treated blood to the patient's body, the output ends of the blood cell output line 13 and the plasma return line 15 are both connected to the input end of the return blood line 16, the input end of the plasma return line 15 is connected to the output end of the plasma diafiltration adsorption device 2, and the input end of the plasma return line 15 is connected to a fresh plasma line 17 for replenishing fresh plasma. After blood is collected, the blood collection tube 12 is sent to the centrifugal plasma separator 11, and the separated blood cells are sent to the return blood tube 16 through the blood cell output tube 13 and finally transported back to the human body. The separated plasma flows out from the plasma output tube 14, and can enter the waste plasma bag 32 through the plasma transfer tube 33, and can also be sent to the plasma diafiltration adsorption device 2 for purification. The purified plasma enters the return blood tube 16 through the plasma return tube 15 and is finally transported back to the human body. When only plasma exchange is performed, fresh plasma can be supplemented through the fresh plasma tube 17.

[0034] In this embodiment, the plasma diafiltration adsorption device 2 includes a filtrate input pipeline 21, a plasma diafiltration adsorption pipeline 22 for diafiltration adsorption of plasma, and a plasma circulation return pipeline 23 for circulating or returning the purified plasma. The input end of the plasma diafiltration adsorption pipeline 22 is connected to the output end of the plasma output pipeline 14, and the output ends of the plasma diafiltration adsorption pipeline 22 and the filtrate input pipeline 21 are both connected to the input end of the plasma circulation return pipeline 23. The output end of the plasma circulation return pipeline 23 is respectively connected to the input ends of the plasma return pipeline 15 and the plasma circulation pipeline 35. The plasma diafiltration adsorption pipeline 22 receives the plasma from the plasma output pipeline 14 for purification treatment such as dialysis, filtration and adsorption. The treated plasma flows out from the plasma circulation return pipeline 23, a part of which enters the plasma return pipeline 15, and the other part enters the plasma return pipeline 15 for circulation to meet the high flow demand of the diafiltration adsorption process.

[0035] In this embodiment, a blood filter 226, a first plasma adsorber 227 and a second plasma adsorber 228 are sequentially arranged on the plasma dialysis filtration adsorption pipeline 22, the lower side hole of the blood filter 226 is connected to a dialysate input pipeline 224, and the upper side hole of the blood filter 226 is connected to a dialysate discharge pipeline 225. Specifically, the first plasma adsorber 227 is a bilirubin adsorber, and the second plasma adsorber 228 is a resin activated carbon adsorber. The blood filter 226, the bilirubin adsorber and the resin activated carbon adsorber can perform effective dialysis filtration adsorption on plasma to remove toxins in plasma, the dialysate input pipeline 224 provides dialysate for the dialysis process, and the dialysate discharge pipeline 225 can recycle the used dialysate.

[0036] In this embodiment, a first connection port 351 that can be connected or disconnected is provided on the plasma circulation pipeline 35, a second connection port 142 that can be connected or disconnected is provided between the plasma output pipeline 14 and the plasma diafiltration adsorption pipeline 22, a third connection port 231 that can be connected or disconnected is provided between the plasma circulation return pipeline 23 and the plasma return pipeline 15, and a tube clamp 4 is provided on both sides of the first connection port 351, the second connection port 142 and the third connection port 231. The three connection ports can connect the three parts of the plasma exchange device 1, the plasma diafiltration adsorption device 2 and the plasma transfer device 3 into a complete all-round plasma purification system for operation, and they can also be disconnected and used separately, such as being divided into two relatively independent systems of centrifugal plasma exchange and membrane blood purification (including membrane plasma exchange, plasma adsorption, hemodiafiltration and other treatment methods), and different modes of artificial liver treatment are performed for different patients at the same time, which has flexibility and versatility.

[0037] In this embodiment, a blood collection pump 121 is provided on the blood collection tube line 12, and the speed of the blood collection pump 121 is 50-60 ml / min. A plasma separation pump 141 is provided on the plasma output line 14, and the speed of the plasma separation pump 141 is 25-30 ml / min. A plasma input pump 151 is provided on the plasma return line 15, and the speed of the plasma input pump 151 is 25-30 ml / min. A plasma circulation drive pump 221 is provided on the plasma diafiltration adsorption line 22, and the speed of the plasma circulation drive pump 221 is 150-180 ml / min. A dialysate pump 2241 is provided on the dialysate input line 224, and the speed of the dialysate pump 2241 is 50-60 ml / min. A waste liquid pump 2251 is provided on the dialysate discharge line 225, and the speed of the waste liquid pump 2251 is 100-120 ml / min, a filtrate pump 211 is provided on the filtrate input pipeline 21, and the speed of the filtrate pump 211 is 50-60 ml / min. Liquid balance can be controlled by adjusting the speed of the plasma separation pump 141, the plasma input pump 151, the filtrate pump 211 and the waste liquid pump 2251 in a linked manner, thereby realizing ultrafiltration. Specifically, the speed of the blood collection pump 121 is set to 60ml / min, the speed of the plasma separation pump 141 is set to 30ml / min, the speed of the plasma input pump 151 is set to 25ml / min, the speed of the plasma circulation drive pump 221 is set to 180ml / min, the speed of the dialysate pump 2241 is set to 50ml / min, the speed of the waste liquid pump 2251 is set to 115ml / min, and the speed of the filtrate pump 211 is set to 60ml / min. At this time, ultrafiltration at a speed of 5ml / min (300ml / h) can be achieved.

[0038] In this embodiment, a first liquid pot 122 and a first liquid level detection sensor 123 for detecting the liquid level of the first liquid pot 122 are provided on the blood collection tube circuit 12, a second liquid pot 222 and a second liquid level detection sensor 223 for detecting the liquid level of the second liquid pot 222 are provided on the plasma dialysis filtration adsorption tube 22, a third liquid pot 161 and a third liquid level detection sensor 162 for detecting the liquid level of the third liquid pot 161 are provided on the blood return tube 16, a fourth liquid pot 212 and a fourth liquid level detection sensor 213 for detecting the liquid level of the fourth liquid pot 212 are provided on the filtrate input tube 21, a fifth liquid pot 152 and a fifth liquid level detection sensor 153 for detecting the liquid level of the fifth liquid pot 152 are provided on the plasma return tube 15, the liquid pot can temporarily store liquid, and the liquid level detection sensor can detect the liquid level in the liquid pot to ensure the normal operation of the system.

[0039] In this embodiment, the first liquid pot 122, the second liquid pot 222 and the third liquid pot 161 are all provided with a pressure detection connecting pipe 5, which is convenient for detecting the pressure condition in the pipeline and is conducive to the normal operation of the system.

[0040] In this embodiment, the first liquid pot 122 and the second liquid pot 222 are both connected to a heparin pump 6 .

[0041] In this embodiment, a first heating component 154 is provided on the plasma return pipeline 15, and a second heating component 232 is provided at one end of the plasma circulation return pipeline 23 connected to the plasma return pipeline 15. The heating component can heat the liquid in the pipeline to a normal physiological temperature to ensure a balanced and stable body temperature of the patient during treatment.

[0042] In this embodiment, a fresh plasma bag 171 is provided at the input end of the fresh plasma pipeline 17, a dialysate bag 2242 is provided at the input end of the dialysate input pipeline 224, a waste liquid bag 2252 is provided at the output end of the dialysate discharge pipeline 225, and a filtrate bag 214 is provided at the input end of the filtrate input pipeline 21. The dialysate bag 2242, the waste liquid bag 2252 and the filtrate bag 214 are all provided with a hanging scale for monitoring the weight. The weight of the filtrate bag 214, the dialysate bag 2242, the waste liquid bag 2252 and the filtrate bag 214 is monitored so that they can be replaced in time when the remaining amount in the bag is insufficient to avoid affecting the treatment.

[0043] In this embodiment, the plasma exchange device 1 is connected to a computer control system that independently controls the plasma exchange device 1, and the plasma diafiltration adsorption device 2 is connected to a computer control system that independently controls the plasma diafiltration adsorption device 2. Specifically, the computer control system can be controlled independently of each other in one computer at the same time, or it can be controlled independently in two computers. When performing universal plasma purification treatment, the two computer control systems can also communicate with each other and work together, and centrifugal plasma exchange and plasma diafiltration adsorption treatment can be performed on a patient through the connection of the pipeline of the present invention. The separate computer control system is convenient for the plasma exchange device 1 and the plasma diafiltration adsorption device 2 to be used separately, that is, they are separated into two independent treatment systems, and centrifugal separation plasma exchange and membrane plasma purification treatment are performed on two different patients respectively. One machine has two uses, and two independent computer control systems can independently monitor the work according to the actual situation without affecting each other, thereby improving the flexibility and versatility of the system.

[0044] The method of using the universal plasma purification system based on the centrifugal plasma separation method of this embodiment is as follows:

[0045] (1) Universal plasma purification therapy using centrifugal separation plasma exchange and plasma diafiltration adsorption:

[0046] like Figure 2 As shown, before treatment, the first connection port 351, the second connection port 142 and the third connection port 231 are disconnected, and heparin saline is used to pre-fill the lines of the plasma exchange device 1 and the plasma diafiltration adsorption device 2 respectively under the control of a computer program.

[0047] First, centrifugal plasma exchange is performed through the centrifugal plasma separator 11, and the fresh plasma pipeline 17 is connected. The fresh plasma is driven by the plasma input pump 151 through the plasma return pipeline 15, and after merging with the blood cells in the blood cell output pipeline 13, it is returned to the patient's body through the blood return pipeline 16. The separated plasma flows out from the plasma output pipeline 14, enters the plasma transfer bag 31 through the plasma transfer pipeline 33, and then enters the waste plasma bag 32 through the plasma discharge pipeline 34.

[0048] like Figure 3 As shown, after the plasma exchange is completed, the tube clamp 4 of the fresh plasma pipeline 17 and the tube clamp 4 of the plasma discharge pipeline 34 near the waste plasma bag 32 are closed, and the first connection port 351, the second connection port 142 and the third connection port 231 are connected to start the plasma diafiltration adsorption treatment: the plasma separated at a low speed by the centrifugal plasma separator 11 flows out from the plasma output pipeline 14 into the plasma diafiltration adsorption pipeline 22, and the plasma retained in the plasma transfer bag 31 also enters the plasma diafiltration adsorption pipeline 22 through the plasma transfer pipeline 33. These plasmas are transported to the hemofilter 226, the bilirubin adsorber and the resin activated carbon adsorber for plasma diafiltration and adsorption under the action of the high-speed plasma circulation drive pump 221. A portion of the purified plasma The plasma is returned to the patient's body after being combined with blood cells through the plasma input pump 151, and the other part of the plasma enters the plasma transfer bag 31 through the plasma circulation pipeline 35, and is combined with the plasma separated at a low speed by the centrifugal plasma separator 11, and is transported to the plasma diafiltration adsorption pipeline 22 by the plasma circulation drive pump 221 for circulation purification. In this way, the circulation purification of plasma is achieved through the plasma transfer device 3, which can meet the differentiated requirements of plasma separation, plasma diafiltration and plasma adsorption on plasma flow rate, solve the contradiction between the low-speed plasma separation of the centrifugal plasma separator 11 and the high plasma flow rate required by the plasma diafiltration adsorption device 2, and can perform high-speed diafiltration and adsorption purification on the separated waste plasma, giving full play to the therapeutic advantages of various purification methods.

[0049] (2) Treatment with centrifugal plasma exchange and membrane blood purification:

[0050] Since the plasma exchange device 1 and the plasma diafiltration adsorption device 2 are independent of each other, two independent systems, a centrifugal separation plasma exchange system and a membrane blood purification system, can be obtained by disconnecting the first connection port 351, the second connection port 142 and the third connection port 231. The centrifugal separation plasma exchange system uses three pumps and the membrane blood purification system uses four pumps, which are independent of each other and do not interfere with each other. They are controlled by their own computer control systems respectively, and can perform centrifugal separation plasma exchange and membrane blood purification (including membrane plasma exchange, plasma adsorption, hemodiafiltration and other treatment methods) for two patients at the same time. Its application is flexible and multifunctional.

[0051] Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Any technician familiar with the art can make many possible changes and modifications to the technical solution of the present invention by using the technical content disclosed above without departing from the scope of the technical solution of the present invention, or modify it into an equivalent embodiment of equivalent changes. Therefore, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention should fall within the scope of protection of the technical solution of the present invention.

Claims

1. An all-purpose plasma purification system based on centrifugal plasma separation method, comprising a plasma exchange device (1) and a plasma diafiltration adsorption device (2), characterized in that: The plasma exchange device (1) comprises a centrifugal plasma separator (11), and the plasma purification system further comprises a plasma transfer device (3) for collecting separated plasma or circulating purified plasma, the plasma transfer device (3) comprising a plasma transfer bag (31) and a waste plasma bag (32), a plasma transfer pipeline (33) being provided between the plasma output end of the plasma exchange device (1) and the plasma transfer bag (31), a plasma discharge pipeline (34) being provided between the plasma transfer bag (31) and the waste plasma bag (32), and a plasma diafiltration adsorption device (2) having a plasma output end and a plasma discharge pipeline (34) being provided between the plasma output end and the plasma discharge pipeline (34). A plasma circulation pipeline (35) is provided, the height of the connection port between the plasma transfer bag (31) and the plasma transfer pipeline (33) is lower than the height of the connection port between the plasma transfer bag (31) and the plasma discharge pipeline (34), the input end of the centrifugal plasma separator (11) is connected to a blood collection tube (12) for collecting patient blood, the output end of the centrifugal plasma separator (11) is connected to a blood cell output pipeline (13) and a plasma output pipeline (14), the plasma output pipeline (14) is connected to the plasma transfer pipeline (33), and the output end of the plasma output pipeline (14) is connected to the plasma diafiltration adsorption device The plasma exchange device (1) is connected to the input end of the plasma diafiltration adsorption device (2), the plasma exchange device (1) further comprising a plasma return line (15) for returning plasma and a blood return line (16) for returning treated blood to the patient's body, the output ends of the blood cell output line (13) and the plasma return line (15) are both connected to the input end of the blood return line (16), the input end of the plasma return line (15) is connected to the output end of the plasma diafiltration adsorption device (2), the input end of the plasma return line (15) is connected to a fresh plasma line (17) for replenishing fresh plasma, the plasma diafiltration adsorption device (2) comprises a filtrate An input pipeline (21), a plasma diafiltration adsorption pipeline (22) for diafiltration adsorption of plasma, and a plasma circulation return pipeline (23) for circulating or returning purified plasma, wherein the input end of the plasma diafiltration adsorption pipeline (22) is connected to the output end of the plasma output pipeline (14), the output ends of the plasma diafiltration adsorption pipeline (22) and the filtrate input pipeline (21) are both connected to the input end of the plasma circulation return pipeline (23), and the output end of the plasma circulation return pipeline (23) is respectively connected to the input ends of the plasma return pipeline (15) and the plasma circulation pipeline (35).

2. The all-purpose plasma purification system based on centrifugal plasma separation method according to claim 1, characterized in that: The plasma dialysis filtration adsorption pipeline (22) is provided with a blood filter (226), a first plasma adsorber (227) and a second plasma adsorber (228) in sequence, the lower side hole of the blood filter (226) is connected to a dialysate input pipeline (224), and the upper side hole of the blood filter (226) is connected to a dialysate discharge pipeline (225).

3. The all-purpose plasma purification system based on centrifugal plasma separation method according to claim 2, characterized in that: The plasma circulation pipeline (35) is provided with a first connection port (351) that can be connected or disconnected, a second connection port (142) that can be connected or disconnected is provided between the plasma output pipeline (14) and the plasma diafiltration adsorption pipeline (22), and a third connection port (231) that can be connected or disconnected is provided between the plasma circulation return pipeline (23) and the plasma return pipeline (15), and tube clamps (4) are provided on both sides of the first connection port (351), the second connection port (142) and the third connection port (231).

4. The all-purpose plasma purification system based on centrifugal plasma separation method according to claim 3, characterized in that: The blood collection tube line (12) is provided with a blood collection pump (121), and the speed of the blood collection pump (121) is 50-60 ml / min. The plasma output line (14) is provided with a plasma separation pump (141), and the speed of the plasma separation pump (141) is 25-30 ml / min. The plasma return line (15) is provided with a plasma input pump (151), and the speed of the plasma input pump (151) is 25-30 ml / min. The plasma diafiltration adsorption line (22) is provided with a plasma circulation drive pump (221), and the speed of the plasma circulation drive pump (221) is 150-180 ml / min. The dialysate input line (224) is provided with a dialysate pump (2241), and the speed of the dialysate pump (2241) is 50-60 ml / min, a waste liquid pump (2251) is provided on the dialysate discharge pipeline (225), and the speed of the waste liquid pump (2251) is 100-120 ml / min, and a filtrate pump (211) is provided on the filtrate input pipeline (21), and the speed of the filtrate pump (211) is 50-60 ml / min.

5. The all-purpose plasma purification system based on centrifugal plasma separation method according to claim 2, characterized in that: The blood collection tube (12) is provided with a first liquid pot (122) and a first liquid level detection sensor (123) for detecting the liquid level of the first liquid pot (122); the plasma dialysis filtration adsorption tube (22) is provided with a second liquid pot (222) and a second liquid level detection sensor (223) for detecting the liquid level of the second liquid pot (222); the blood return tube (16) is provided with a third liquid pot (161) and a third liquid level detection sensor (162) for detecting the liquid level of the third liquid pot (161); the filtrate input tube ( A fourth liquid pot (212) and a fourth liquid level detection sensor (213) for detecting the liquid level of the fourth liquid pot (212) are provided on the said plasma return pipeline (15); a fifth liquid pot (152) and a fifth liquid level detection sensor (153) for detecting the liquid level of the fifth liquid pot (152) are provided on the said plasma return pipeline (15); a pressure detection connecting tube (5) is provided on the said first liquid pot (122), the second liquid pot (222) and the third liquid pot (161); and a heparin pump (6) is connected to the said first liquid pot (122) and the second liquid pot (222).

6. The all-purpose plasma purification system based on centrifugal plasma separation method according to claim 2, characterized in that: The plasma return pipeline (15) is provided with a first heating component (154); the end of the plasma circulation return pipeline (23) connected to the plasma return pipeline (15) is provided with a second heating component (232); the input end of the fresh plasma pipeline (17) is provided with a fresh plasma bag (171); the input end of the dialysate input pipeline (224) is provided with a dialysate bag (2242); the output end of the dialysate discharge pipeline (225) is provided with a waste liquid bag (2252); the input end of the filtrate input pipeline (21) is provided with a filtrate bag (214); and the dialysate bag (2242), the waste liquid bag (2252) and the filtrate bag (214) are all provided with hanging scales for monitoring weight.

7. The universal plasma purification system based on centrifugal plasma separation method according to any one of claims 1 to 6, characterized in that: The plasma exchange device (1) is connected to a computer control system that independently controls the plasma exchange device (1), and the plasma diafiltration adsorption device (2) is connected to a computer control system that independently controls the plasma diafiltration adsorption device (2).